- Home
- Companies
- Precision NanoSystems
- Products
- Precision - Model GenVoy-ILM - Lipid ...
Precision - Model GenVoy-ILM -Lipid Nanoparticle T Cell Kit (LNP) for mRNA
Rethink Cell Therapy with Lipid Nanoparticles. Lipid Nanoparticle (LNP) based technology enables researchers to establish a clinically relevant, scalable method for ex vivo gene delivery.
The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix. It is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges.
This kit enables researchers to establish a clinically-relevant and scalable method for ex vivo gene delivery to advance the development of T cell therapies. It can be used at various stages of cell therapy research and development from discovery to preclinical across the NxGen™ microfluidics instrument platform.
GREATER PROPORTION OF ENGINEERED CELLS
The GenVoy-ILM T Cell Kit for mRNA delivers mRNA into activated primary T cells consistently with high efficiency.
HIGH CELL VIABILITY
Nucleic acids delivered using the GenVoy-ILM T Cell Kit for mRNA are potent without causing cytotoxicity, resulting in highly viable cells that can be assayed in vitro and in vivo.
TUNABLE BIOLOGICAL OUTCOMES
